1. Home
  2. Labeler Index
  3. Hospira, Inc.
  4. 0409-1902
  5. NDC Package Code: 0409-1902-01 Procainamide Hydrochloride

NDC Package 0409-1902-01 Procainamide Hydrochloride

Injection, Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0409-1902-01
Package Description:
25 CARTON in 1 CASE / 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1902-11) / 10 mL in 1 VIAL, MULTI-DOSE
Product Code:
0409-1902
Proprietary Name:
Procainamide Hydrochloride
Non-Proprietary Name:
Procainamide Hydrochloride
Substance Name:
Procainamide Hydrochloride
Usage Information:
Procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. Because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided.Initiation of procainamide treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital.Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias.Because procainamide has the potential to produce serious hematological disorders (0.5 percent) particularly leukopenia or agranulocytosis (sometimes fatal), its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment clearly outweigh the risks. (see WARNINGS and Boxed Warning.)
11-Digit NDC Billing Format:
00409190201
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 857886 - procainamide HCl 100 MG/ML Injectable Solution
  • RxCUI: 857886 - procainamide hydrochloride 100 MG/ML Injectable Solution
  • RxCUI: 857962 - procainamide HCl 500 MG/ML Injectable Solution
  • RxCUI: 857962 - procainamide hydrochloride 500 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hospira, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • PROCAINAMIDE HYDROCHLORIDE 100 mg/mL
    • Pharmacologic Class(es):
  • Antiarrhythmic - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA089069
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-08-2006
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0409-1902-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00409190201J2690Procainamide hcl injection1 GM1025125

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0409-1902-01?

    The NDC Packaged Code 0409-1902-01 is assigned to a package of 25 carton in 1 case / 1 vial, multi-dose in 1 carton (0409-1902-11) / 10 ml in 1 vial, multi-dose of Procainamide Hydrochloride, a human prescription drug labeled by Hospira, Inc.. The product's dosage form is injection, solution and is administered via intramuscular; intravenous form.

    Is NDC 0409-1902 included in the NDC Directory?

    Yes, Procainamide Hydrochloride with product code 0409-1902 is active and included in the NDC Directory. The product was first marketed by Hospira, Inc. on March 08, 2006 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0409-1902-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0409-1902-01?

    The 11-digit format is 00409190201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20409-1902-015-4-200409-1902-01